Drug profile · INN
mipomersen sodium
KYNAMRO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
mipomersen sodium (KYNAMRO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN mipomersen sodium
Brand KYNAMRO
Route SUBCUTANEOUS
Formulation SOLUTION
ATC code C10AX11
Frequently asked questions
What is mipomersen sodium?
mipomersen sodium (KYNAMRO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for mipomersen sodium?
KYNAMRO is a marketed brand name for mipomersen sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mipomersen sodium?
mipomersen sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.